Salary vs. wRVU Production Pay: How to Compare

The three pay structures, in plain terms

Almost every employed-physician offer is a variation on three models. Understanding which one you are being offered — and how it behaves as your volume moves up or down — is the difference between an informed decision and a guess.

• Straight salary. A fixed annual amount, paid regardless of how many work RVUs (wRVUs) you generate. Predictable, but with no automatic upside if you produce more than expected.
• Base + production. A guaranteed base salary, plus a productivity bonus once you cross a wRVU threshold. The bonus is typically calculated as (actual wRVUs − threshold) × your $/wRVU rate. This is the most common structure for established employed physicians.
• Pure production. Income is simply total wRVUs × $/wRVU, often with a modest draw or guarantee for the first year or two. Maximum upside, maximum exposure to volume swings.

The lever in two of these three models is the $/wRVU conversion rate — and that is the number most often misunderstood, so it is worth getting right before you model anything.

First, don't confuse the two "conversion" numbers

There are two completely different multipliers floating around physician compensation, and articles routinely conflate them. They are not interchangeable and they are not even on the same scale.

• The Medicare conversion factor (CF) is set annually by CMS and converts a service's total RVUs (work + practice expense + malpractice, geographically adjusted) into Medicare's allowed payment to the practice. It prices a service to the payer. For CY 2026, the CMS Final Rule (CMS-1832-F) created — for the first time — a statutory split: $33.57 for qualifying APM participants and $33.40 for non-qualifying physicians, both up from the single 2025 CF of $32.35. A blanket "2026 conversion factor is X" claim is now imprecise.
• Your employer $/wRVU rate is a privately negotiated compensation rate that multiplies your work RVUs only to compute your pay. It prices your labor to the employer.

Crucially, the Medicare CF is not what you are paid per wRVU. Employer rates typically run roughly 1.5x to 3x the Medicare CF, precisely because they divide a physician's total compensation by clinical work RVUs only. Over recent years the CF has trended down (about $36.04 in 2019 to $33.40 in 2026) even as market compensation rose roughly 20–25% — which is exactly why the two numbers keep diverging. When you model an offer, always use the negotiated employer $/wRVU, never the Medicare CF.

What a realistic $/wRVU rate looks like in 2026

Employer rates come from survey benchmarks (MGMA 2025 Provider Compensation, SullivanCotter's October 2025 release, and AMGA 2025), not from CMS. These are medians derived as total cash compensation divided by clinical wRVUs, and they vary materially by geography, setting, percentile, call burden, and subspecialty. Treat them as ranges, not a single national number.

• Primary care (Family Medicine, Internal Medicine, Hospitalist): roughly $55–65/wRVU — for example FM ~$58, IM ~$62, Hospitalist ~$63. Pediatrics sits lower, around $40–45.
• Medical specialties: a wide $52–78/wRVU spread — Radiology ~$52, Neurology ~$67, Cardiology ~$72, Gastroenterology ~$78, with Hematology/Oncology exceeding $90.
• Surgical/procedural: roughly $75–82/wRVU — General Surgery ~$75, Orthopedic Surgery ~$82.

One reason $/wRVU alone never tells the whole income story: procedural specialties also generate far higher volume (often 7,000–10,000+ wRVUs/year) than primary care (~4,500–6,200/year). Rate and volume both matter. Also note the data vintage — the CMS CF is an official current-year statutory figure, while any "2026" comp rate is an estimate built on the latest (2025) survey data, not a published number.

How to model each structure at your expected volume

The only honest way to compare offers is to project all three at the same realistic wRVU estimate — ideally a conservative, an expected, and a stretch case. Use your actual or anticipated annual wRVUs (from prior years, a predecessor's panel, or specialty benchmarks), then run the arithmetic.

Straight salary: Income = the stated salary. The only modeling question is whether the salary implies a fair implied $/wRVU. Divide the salary by your expected wRVUs; if a $300,000 salary assumes 5,000 wRVUs, that is an implied $60/wRVU. Compare that to benchmark to see whether you are leaving money on the table at higher volumes.

Base + production: Income = base + max(0, (expected wRVUs − threshold) × rate). Find the threshold where the bonus turns on. Below it, you earn only the base; above it, every wRVU adds rate dollars. Model the threshold carefully — a high threshold can make a generous-looking base effectively a salary in disguise.

Pure production: Income = expected wRVUs × rate (plus any draw, which is usually recoverable against production). This is the most volatile: a 15% volume miss is a 15% pay cut.

Build a simple three-column table — conservative / expected / stretch volume — and fill in projected income for each model. The structure that "wins" almost always depends on which volume scenario you actually believe.

A worked break-even example

Suppose a primary-care physician is choosing between two offers at a $60/wRVU rate:

• Offer A — straight salary: $300,000 flat.
• Offer B — base + production: $240,000 base, plus $60/wRVU for every wRVU above a 4,000 threshold.

Offer B matches Offer A's $300,000 when the production bonus equals $60,000. That requires (wRVUs − 4,000) × $60 = $60,000, i.e. 1,000 wRVUs above the threshold, or 5,000 wRVUs total — the break-even point.

• At 4,500 wRVUs, Offer B pays $240,000 + (500 × $60) = $270,000 — salary wins by $30,000.
• At 5,000 wRVUs, both pay $300,000 — a wash.
• At 5,800 wRVUs, Offer B pays $240,000 + (1,800 × $60) = $348,000 — production wins by $48,000.

The decision reduces to a single honest question: do you expect to land above or below 5,000 wRVUs? If your realistic expected case is 5,500+, the production deal is worth real money. If volume is uncertain — a new market, an unbuilt panel, a referral-dependent specialty — the salary's floor may be worth more than the forgone upside.

Pros, cons, and risk considerations

Straight salary gives you a predictable floor and shields you from volume shocks (a slow ramp, a leave of absence, a payer mix you can't control). The cost is forgone upside and the risk that, if you out-produce the implied rate, you are effectively subsidizing the employer. Watch for productivity "expectations" baked into the contract that can be used to justify non-renewal.

Base + production is the popular middle ground: a floor plus genuine upside. The risks live in the fine print — the threshold height, whether the rate is tiered, whether the rate can be adjusted downward at the employer's discretion, and how wKbRVUs are credited (CPT-based work RVUs versus collections-based formulas behave very differently).

Pure production rewards high, controllable volume but transfers nearly all risk to you: scheduling gaps, no-shows, EHR downtime, denied claims, and seasonal dips all hit your income directly. It suits established physicians with full schedules and high procedural throughput far better than new entrants building a panel.

Beyond the formula, pressure-test these: the wRVU credit definition, any rate adjustment or floor/ceiling clauses, draw recoverability, and how mid-year leave affects thresholds (prorated or not). A model is only as good as the contract language behind each variable.

The risk most comparisons forget: malpractice tail

When you compare offers, the malpractice structure can quietly outweigh a few dollars of $/wRVU — because of tail coverage. If the position uses a claims-made policy (most do), a claim is covered only if the incident occurred after the retroactive date and the claim is reported while the policy is active. When you leave, later-reported claims for your covered period are not covered unless you buy a tail (an extended reporting endorsement) from the departing carrier, or your next employer grants nose (prior-acts) coverage. You need one or the other — never both.

This matters financially because tail is a one-time lump sum, typically priced at 1.5x to 2x your mature annual premium (the broader quoted band runs 150–300%). In high-risk specialties it can reach $50,000–$150,000, due at the moment you depart. By contrast, an occurrence policy covers any incident during the policy period no matter when reported, so it never needs a tail (a common point of confusion — occurrence policies do not need tail).

So when weighing a salary offer against a production offer, ask who pays the tail and get it in writing. Common structures: the employer pays if it terminates you without cause (or you leave for the employer's breach); you pay if you resign without cause; or a sliding scale where the employer's share grows with tenure (e.g., 20% per year, reaching 100% after five years). Some carriers also grant a free "earned" retirement tail after ~5 years of continuous coverage and full retirement (often with an age threshold) — but that is a carrier benefit, not an employer promise, and contract silence usually leaves the bill with you. A $10,000/year edge in production pay is easily erased by a $100,000 tail you didn't see coming.